Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro (Q24563574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

David A. Isenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

A J Wilson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

I J Mackie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

S J Machin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Pathology

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

908-911

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway

27 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Thrombosis in patients with the lupus anticoagulant

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Structure and function of protein C.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Thromboembolism in patients with the 'lupus'-type circulating anticoagulant

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein I

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501616

In vitro activation of the contact activation system (Hageman factor system) in plasma by acidic phospholipids and the inhibitory effect of I on this activation

30 May 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

A second plasma inhibitor of activated protein C: alpha 1-antitrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Beta 2-glycoprotein I deficiency and the risk of thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Intrauterine death and circulating anticoagulant ("antithromboplastin")

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Possible relationship between lupus inhibitor and recurrent abortion in young women

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Characterization of the interaction between β2-glycoprotein i and mitochondria, platelets, liposomes and bile acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8227406

12 December 2020

Deficiency of protein C in congenital thrombotic disease

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FJCP.46.10.908

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1136/JCP.46.10.908

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8227406%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

PubMed publication ID

8227406

1 reference